SECOND LINE ERLOTINIB IN NON-SMALL CELL LUNG CANCER: A LOCAL EXPERIENCE

被引：0
|
作者：
Smith, C. F. [1 ]
Garcia-Alonso, Angel [1 ]
Drury, G. [1 ]
Gostage, A. [1 ]
Smith, N. [1 ]
机构：
[1] Betsi Cadwaladr Univ Hlth Board, N Wales Canc Treatment Ctr, Bangor, Gwynedd, Wales
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
erlotinib; second line; NSCLC;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：S1180 / S1181
页数：2
相关论文
共 50 条
  • [41] Preliminary Results of the SENECA (SEcond Line NintEdanib in Non-Small Cell Lung CAncer) Trial: An Italian Experience
    Capelletto, E.
    Migliorino, M. R.
    Morabito, A.
    Chiari, R.
    Grossi, F.
    Tiseo, M.
    Di Costanzo, F.
    Delmonte, A.
    Romano, G.
    Misino, A.
    Scotti, V.
    Gregorc, V.
    Pisconti, S.
    Ceresoli, G.
    Del Conte, A.
    Ciuffreda, L.
    Colantonio, I.
    Bria, E.
    Ricciardi, S.
    Manzo, A.
    Metro, G.
    Morelli, A. M.
    Critelli, R.
    Stura, I.
    Migliaretti, G.
    Novello, S.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S490 - S491
  • [42] Gefitinib or Erlotinib in the Treatment of Advanced Non-small Cell Lung Cancer
    Shao, Yu-Yun
    Lin, Chia-Chi
    Yang, Chih-Hsin
    DISCOVERY MEDICINE, 2010, 9 (49) : 538 - 545
  • [43] Erlotinib for the treatment of brain metastases in non-small cell lung cancer
    Brower, Jeffrey V.
    Robins, H. Ian
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (07) : 1013 - 1021
  • [44] MicroRNA markers for erlotinib resistance in non-small cell lung cancer
    Nelson, Kristen
    Ranade, Aarati
    Kashey, Trevor
    Kingsley, Chris
    Weiss, Glen
    CANCER RESEARCH, 2009, 69
  • [45] Cutaneous complications of erlotinib in the treatment of non-small cell lung cancer
    Preda, V.
    Mann, S.
    Lee, S.
    HONG KONG JOURNAL OF DERMATOLOGY & VENEREOLOGY, 2008, 16 (03): : 133 - 141
  • [46] Use review of Erlotinib in advanced non-small cell lung cancer
    Alvarez-Payero, M.
    Ucha-Samartin, M.
    Martinez-Lopez-de-Castro, N.
    Campelo-Sanchez, E.
    Alvarez-Seoane, J.
    Vazquez-Lopez, C.
    Inaraja-Bobo, M. T.
    Perez Parente, D.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2011, 33 (02) : 438 - 438
  • [47] Intercalation of Erlotinib and Pemetrexed in the Treatment of Non-Small Cell Lung Cancer
    Li, Tianhong
    Lara, Primo N., Jr.
    Mack, Philip C.
    Perez-Soler, Roman
    Gandara, David R.
    CURRENT DRUG TARGETS, 2010, 11 (01) : 85 - 94
  • [48] Review of erlotinib in the treatment of advanced non-small cell lung cancer
    Ganjoo, Kristen N.
    Wakelee, Heather
    BIOLOGICS-TARGETS & THERAPY, 2007, 1 (04): : 335 - 346
  • [49] Erlotinib: a new therapeutic approach for non-small cell lung cancer
    Bonomi, P
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (08) : 1395 - 1401
  • [50] ERLOTINIB IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) TREATMENT
    Goncalves, Ivone M.
    Monteiro, Regina
    Neves, Sofia
    Conde, Sara
    Campainha, Sergio
    Parente, Barbara
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1298 - S1298
12345